the beta-1 selective , hydrophilic adrenoceptor blocking drug atenolol ( 100 mg daily ) was compared to the non-selective , lipid-soluble beta-blocker propranolol ( 240 mg daily ) , and to placebo , in a double-blind cross-over study in 24 patients with essential tremor .
C0033497
propranolol
C0270736
essential tremor